·ì±Õ¤¬¤ó¤Î°ì¼ï¤Î°À¥ê¥ó¥Ñ¼ð¤¬µ¯¤¤ë»ÅÁȤߤò¡¢¾®ÀîÀ¿»Ê¡¦ÅìµþÂçɱ¡ÆÃǤ½Ú¶µ¼ø(·ì±Õ¼ðáç³Ø)¤é¤¬²òÌÀ¤·¡¢4ÆüÉդαѲʳػï¥Í¥¤¥Á¥ã¡¼ÅÅ»ÒÈǤËȯɽ¤·¤¿¡£°ìÉô¤Î°À¥ê¥ó¥Ñ¼ð¤Ç¤Ï¡¢°ß±ê¤Ê¤ÉËýÀŪ¤Ê±ê¾É¤¬°ú¤¶â¤À¤Ã¤¿¡£±ê¾ÉÍÞÀ©¤¬°À¥ê¥ó¥Ñ¼ð¤Î¼£ÎŤˤĤʤ¬¤ë²ÄǽÀ¤ò¼¨¤¹À®²Ì¤È¤·¤ÆÃíÌܤµ¤ì¤½¤¦¤À¡£
°À¥ê¥ó¥Ñ¼ð¤Ï¡¢Ìȱֵ¡Ç½¤òô¤¦¥ê¥ó¥Ñµå¤Ë¤Ç¤¤ë¤¬¤ó¤Ç¡¢¹ñÆâ¤ÇǯÌó8500¿Í»àË´¤·¤Æ¤¤¤ë¡£
¸¦µæ¥Á¡¼¥à¤Ï¡¢°äÅÁ»Ò¤ò¹½À®¤¹¤ëʪ¼Á¡Ö±ö´ð¡×¤ÎÇÛÎó¤Î¸Ä¿Íº¹¤ò¹â¸úΨ¤Ç¸¡½Ð¤¹¤ëµ»½Ñ¤ò³«È¯¡¢°À¥ê¥ó¥Ñ¼ð´µ¼ÔÌó300¿Í¤ÇÄ´¤Ù¤¿¡£¤¹¤ë¤È¡¢¼ç¤Ë¾Ã²½´É¤Ë¤Ç¤¤ë¡Ö¥Þ¥ë¥È¥ê¥ó¥Ñ¼ð¡×¤Ê¤É2¼ïÎà¤Î°À¥ê¥ó¥Ñ¼ð¤Ç¤Ï¡¢Ìó2³ä¤Î´µ¼Ô¤¬¡¢°äÅÁ»ÒA20¤ÎÇÛÎó¤ËÊѰۤ¬¤¢¤êƯ¤¤¤Æ¤¤¤Ê¤«¤Ã¤¿¡£
¤³¤Î°äÅÁ»Ò¤Ï¡¢±ê¾ÉȯÀ¸»þ¤Ë¥ê¥ó¥Ñµå¤¬ºÝ¸Â¤Ê¤¯Áý¿£¤·¤Ê¤¤¤è¤¦¥Ö¥ì¡¼¥Ìò¤È¤Ê¤Ã¤Æ¤¤¤ë¡£A20¤¬Æ¯¤«¤Ê¤¤°À¥ê¥ó¥Ñ¼ðºÙ˦¤ò¥Þ¥¦¥¹¤Ë°Ü¿¢¤¹¤ë¤È¡¢¥ê¥ó¥Ñµå¤¬°Û¾ïÁý¿£¡¢¤¬¤ó¤òȯ¾É¤·¤¿¡£A20¤¬µ¡Ç½¤·¤Ê¤¤°À¥ê¥ó¥Ñ¼ðºÙ˦¤â¡¢±ê¾É¤ÇÀ¸¤¸¤ë»É·ãʪ¼Á¤¬¤Ê¤¤¤ÈÁý¿£¤»¤º¡¢±ê¾É¤ÎÍ̵¤¬¤¬¤óºÙ˦Áý¿£¤òº¸±¦¤·¤Æ¤¤¤ë¤³¤È¤¬È½ÌÀ¤·¤¿¡£
([°À¥ê¥ó¥Ñ¼ð]ËýÀ±ê¾É¤¬°ú¤¶â¡¡ÅìÂç¥Á¡¼¥à²òÌÀ)
°À¥ê¥ó¥Ñ¼ð¤Ï¡¢¥ê¥ó¥ÑÀá¤äÁ´¿È¤Î¥ê¥ó¥ÑÁÈ¿¥(¶»Á£¡¢ç£Â¡¡¢Ù¨ÅíÁ£¡¢¥ê¥ó¥Ñ´É¤Ê¤É)¤Ë¸ºß¤¹¤ë¡¢¥ê¥ó¥Ñµå·ÏºÙ˦¤Î°À¼ðáç¤Ç¤¹(¼ðáç¤Îµ¯¸»¤ä¡¢¼ðáç²½¤Î²áÄø¤âñ°ì¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó)¡£
¼ãǯ¼Ô¤Ë¤â¤ß¤é¤ì¤Þ¤¹¤¬¡¢30ºÐ°Ê¾å¤Ç¤ÏǯÎð¤È¤È¤â¤ËÁý²Ã¤·¤Þ¤¹¡£Ã˽÷Èæ¤Ï2¡§1¤ÇÃËÀ¤Ë¿¤¤¤Ç¤¹¡£ÆüËܤΰÀ¥ê¥ó¥Ñ¼ð¤ÎȯÀ¸Î¨¤Ï10Ëü¿ÍÅö¤¿¤êÌó5¿Í¤Ç¤¢¤ê¡¢²¤ÊƤÎÌó12¿Í¤ËÈæ¤Ù¤ÆÄ㤤¤Ç¤¹(¤³¤ÎÍýͳ¤È¤·¤Æ¤Ï¡¢ÀáÀ¥ê¥ó¥Ñ¼ð¤Ç¤¢¤ëHodgkinɤÈßÉ˦À¥ê¥ó¥Ñ¼ð¤ÎȯÀ¸Î¨¤¬Ä㤤¤¿¤á¤Ç¤¹¡£Àá³°À¥ê¥ó¥Ñ¼ð¤ÎÀê¤á¤ë³ä¹ç¤¬ÁêÂÐŪ¤Ë¹â¤¯¤Ê¤Ã¤Æ¤¤¤Þ¤¹)¡£
ÉÂÍýÁÈ¿¥³ØÅª½ê¸«¤«¤é¡¢Hodgkin(¥Û¥¸¥¥ó)ɤÈÈóHodgkin¥ê¥ó¥Ñ¼ð(NHL)¤È¤ËÂçÊ̤µ¤ì¤Þ¤¹¡£¥Û¥¸¥¥óɤϡ¢¥ê¡¼¥É-¥¹¥Æ¥ë¥ó¥Ù¥ë¥°(Reed-Sternberg)ºÙ˦¤Î½Ð¸½¤¹¤ëÆÃħ¤Î¤¢¤ë¥ê¥ó¥Ñ¼ð¤Ç¤¹(¤¿¤À¡¢¤½¤Îµ¯¸»¤Ï¤Þ¤Àʬ¤«¤Ã¤Æ¤Þ¤»¤ó)¡£
Èó¥Û¥¸¥¥ó¥ê¥ó¥Ñ¼ð¤ÎÂç¿¿ô¤Ï¡¢B¥ê¥ó¥Ñµå¤¢¤ë¤¤¤ÏT¥ê¥ó¥Ñµå¤Î¼ðáç¤Ç¤¢¤ë¤³¤È¤¬È½ÌÀ¤·¤Æ¤¤¤Þ¤¹¡£¤½¤³¤Ç¡¢Èó¥Û¥¸¥¥ó¥ê¥ó¥Ñ¼ð¤Ï¡¢·ÁÂÖ³ØÅªÆÃħ(ÉÂÍý³ØÅªÊ¬Îà)¡¢ºÙ˦·Ï¼ÁŪÆÃħ(BºÙ˦À¡¢TºÙ˦À¡¢NKºÙ˦À)¡¢À÷¿§ÂΡ¦°äÅÁ»Ò¾ðÊó¤Ê¤É¤ò¤â¤È¤ËʬÎव¤ì¤Þ¤¹¡£¤Þ¤¿¡¢È¯¾É¤·¤Æ¤«¤é¤Îɵ¤¤Î¿Ê¹Ô®Å٤ˤè¤Ã¤Æ¤âʬ¤±¤ë¤³¤È¤¬¤Ç¤¤Þ¤¹(ǯñ°Ì¤Ç¿Ê¹Ô¤¹¤ëÄã°ÀÅÙ¡¢·îñ°Ì¤Ç¿Ê¹Ô¤¹¤ëÃæ°ÀÅÙ¡¢½µÃ±°Ì¤Ç¿Ê¹Ô¤¹¤ë¹â°ÀÅ٤ʤÉ)¡£
°ìÈÌŪ¤ËÄã°ÀÅ٤Τâ¤Î¤Ë¤Ï¡¢ßÉ˦À¥ê¥ó¥Ñ¼ð¡¢MALT¥ê¥ó¥Ñ¼ð¤Ê¤É¤¬³ºÅö¤·¡¢Ãæ°ÀÅ٤Τâ¤Î¤Ë¤Ï¤Ó¤Þ¤óÀÂçºÙ˦À£ÂºÙ˦À¥ê¥ó¥Ñ¼ð¤ä̤ʬ²½ÂçºÙ˦¥ê¥ó¥Ñ¼ð¤Ê¤É¡¢¹â°ÀÅ٤Τâ¤Î¤Ë¤Ï¥ê¥ó¥Ñ²êµåÀ¥ê¥ó¥Ñ¼ð¡¢¥Ð¡¼¥¥Ã¥È¥ê¥ó¥Ñ¼ð¤Ê¤É¤¬³ºÅö¤·¤Þ¤¹¡£
¤³¤Î¤è¤¦¤Ë¡¢¡Ö°À¥ê¥ó¥Ñ¼ð¡×¤È¤¤¤¦ÉÂ̾¤Ï¡¢¤µ¤Þ¤¶¤Þ¤Ê¥ê¥ó¥Ñ·ÏÁÈ¿¥¤Î°À¼ðáç¤òÂ礤¯¤Þ¤È¤á¤Æ¸Æ¤ó¤Ç¤¤¤Þ¤¹¡£¤½¤ì¤¾¤ìÀ¼Á¤¬°Û¤Ê¤ë¤¿¤á¡¢ºÇŬ¤Ê¼£ÎŤòÁªÂò¤¹¤ë¾å¤Ç¤Ï¡¢Ž¢°À¥ê¥ó¥Ñ¼ð¤ÎÃæ¤Î¤É¤Î¤è¤¦¤Ê¥¿¥¤¥×¤Ê¤Î¤«Ž£¤È¤¤¤¦¤³¤È¤¬Èó¾ï¤Ë½ÅÍפˤʤäƤ¤Þ¤¹¡£
¾åµ¤Î¤è¤¦¤Ê¼ç¤Ë¾Ã²½´É¤Ë¤Ä¤¤¤Æ¤Ï¡¢°Ê²¼¤Î¤è¤¦¤ËÀâÌÀ¤Ç¤¤ë¤È»×¤ï¤ì¤Þ¤¹¡£
°À¥ê¥ó¥Ñ¼ð¤Ï¡¢Ìȱֵ¡Ç½¤òô¤¦¥ê¥ó¥Ñµå¤Ë¤Ç¤¤ë¤¬¤ó¤Ç¡¢¹ñÆâ¤ÇǯÌó8500¿Í»àË´¤·¤Æ¤¤¤ë¡£
¸¦µæ¥Á¡¼¥à¤Ï¡¢°äÅÁ»Ò¤ò¹½À®¤¹¤ëʪ¼Á¡Ö±ö´ð¡×¤ÎÇÛÎó¤Î¸Ä¿Íº¹¤ò¹â¸úΨ¤Ç¸¡½Ð¤¹¤ëµ»½Ñ¤ò³«È¯¡¢°À¥ê¥ó¥Ñ¼ð´µ¼ÔÌó300¿Í¤ÇÄ´¤Ù¤¿¡£¤¹¤ë¤È¡¢¼ç¤Ë¾Ã²½´É¤Ë¤Ç¤¤ë¡Ö¥Þ¥ë¥È¥ê¥ó¥Ñ¼ð¡×¤Ê¤É2¼ïÎà¤Î°À¥ê¥ó¥Ñ¼ð¤Ç¤Ï¡¢Ìó2³ä¤Î´µ¼Ô¤¬¡¢°äÅÁ»ÒA20¤ÎÇÛÎó¤ËÊѰۤ¬¤¢¤êƯ¤¤¤Æ¤¤¤Ê¤«¤Ã¤¿¡£
¤³¤Î°äÅÁ»Ò¤Ï¡¢±ê¾ÉȯÀ¸»þ¤Ë¥ê¥ó¥Ñµå¤¬ºÝ¸Â¤Ê¤¯Áý¿£¤·¤Ê¤¤¤è¤¦¥Ö¥ì¡¼¥Ìò¤È¤Ê¤Ã¤Æ¤¤¤ë¡£A20¤¬Æ¯¤«¤Ê¤¤°À¥ê¥ó¥Ñ¼ðºÙ˦¤ò¥Þ¥¦¥¹¤Ë°Ü¿¢¤¹¤ë¤È¡¢¥ê¥ó¥Ñµå¤¬°Û¾ïÁý¿£¡¢¤¬¤ó¤òȯ¾É¤·¤¿¡£A20¤¬µ¡Ç½¤·¤Ê¤¤°À¥ê¥ó¥Ñ¼ðºÙ˦¤â¡¢±ê¾É¤ÇÀ¸¤¸¤ë»É·ãʪ¼Á¤¬¤Ê¤¤¤ÈÁý¿£¤»¤º¡¢±ê¾É¤ÎÍ̵¤¬¤¬¤óºÙ˦Áý¿£¤òº¸±¦¤·¤Æ¤¤¤ë¤³¤È¤¬È½ÌÀ¤·¤¿¡£
([°À¥ê¥ó¥Ñ¼ð]ËýÀ±ê¾É¤¬°ú¤¶â¡¡ÅìÂç¥Á¡¼¥à²òÌÀ)
°À¥ê¥ó¥Ñ¼ð¤Ï¡¢¥ê¥ó¥ÑÀá¤äÁ´¿È¤Î¥ê¥ó¥ÑÁÈ¿¥(¶»Á£¡¢ç£Â¡¡¢Ù¨ÅíÁ£¡¢¥ê¥ó¥Ñ´É¤Ê¤É)¤Ë¸ºß¤¹¤ë¡¢¥ê¥ó¥Ñµå·ÏºÙ˦¤Î°À¼ðáç¤Ç¤¹(¼ðáç¤Îµ¯¸»¤ä¡¢¼ðáç²½¤Î²áÄø¤âñ°ì¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó)¡£
¼ãǯ¼Ô¤Ë¤â¤ß¤é¤ì¤Þ¤¹¤¬¡¢30ºÐ°Ê¾å¤Ç¤ÏǯÎð¤È¤È¤â¤ËÁý²Ã¤·¤Þ¤¹¡£Ã˽÷Èæ¤Ï2¡§1¤ÇÃËÀ¤Ë¿¤¤¤Ç¤¹¡£ÆüËܤΰÀ¥ê¥ó¥Ñ¼ð¤ÎȯÀ¸Î¨¤Ï10Ëü¿ÍÅö¤¿¤êÌó5¿Í¤Ç¤¢¤ê¡¢²¤ÊƤÎÌó12¿Í¤ËÈæ¤Ù¤ÆÄ㤤¤Ç¤¹(¤³¤ÎÍýͳ¤È¤·¤Æ¤Ï¡¢ÀáÀ¥ê¥ó¥Ñ¼ð¤Ç¤¢¤ëHodgkinɤÈßÉ˦À¥ê¥ó¥Ñ¼ð¤ÎȯÀ¸Î¨¤¬Ä㤤¤¿¤á¤Ç¤¹¡£Àá³°À¥ê¥ó¥Ñ¼ð¤ÎÀê¤á¤ë³ä¹ç¤¬ÁêÂÐŪ¤Ë¹â¤¯¤Ê¤Ã¤Æ¤¤¤Þ¤¹)¡£
ÉÂÍýÁÈ¿¥³ØÅª½ê¸«¤«¤é¡¢Hodgkin(¥Û¥¸¥¥ó)ɤÈÈóHodgkin¥ê¥ó¥Ñ¼ð(NHL)¤È¤ËÂçÊ̤µ¤ì¤Þ¤¹¡£¥Û¥¸¥¥óɤϡ¢¥ê¡¼¥É-¥¹¥Æ¥ë¥ó¥Ù¥ë¥°(Reed-Sternberg)ºÙ˦¤Î½Ð¸½¤¹¤ëÆÃħ¤Î¤¢¤ë¥ê¥ó¥Ñ¼ð¤Ç¤¹(¤¿¤À¡¢¤½¤Îµ¯¸»¤Ï¤Þ¤Àʬ¤«¤Ã¤Æ¤Þ¤»¤ó)¡£
Èó¥Û¥¸¥¥ó¥ê¥ó¥Ñ¼ð¤ÎÂç¿¿ô¤Ï¡¢B¥ê¥ó¥Ñµå¤¢¤ë¤¤¤ÏT¥ê¥ó¥Ñµå¤Î¼ðáç¤Ç¤¢¤ë¤³¤È¤¬È½ÌÀ¤·¤Æ¤¤¤Þ¤¹¡£¤½¤³¤Ç¡¢Èó¥Û¥¸¥¥ó¥ê¥ó¥Ñ¼ð¤Ï¡¢·ÁÂÖ³ØÅªÆÃħ(ÉÂÍý³ØÅªÊ¬Îà)¡¢ºÙ˦·Ï¼ÁŪÆÃħ(BºÙ˦À¡¢TºÙ˦À¡¢NKºÙ˦À)¡¢À÷¿§ÂΡ¦°äÅÁ»Ò¾ðÊó¤Ê¤É¤ò¤â¤È¤ËʬÎव¤ì¤Þ¤¹¡£¤Þ¤¿¡¢È¯¾É¤·¤Æ¤«¤é¤Îɵ¤¤Î¿Ê¹Ô®Å٤ˤè¤Ã¤Æ¤âʬ¤±¤ë¤³¤È¤¬¤Ç¤¤Þ¤¹(ǯñ°Ì¤Ç¿Ê¹Ô¤¹¤ëÄã°ÀÅÙ¡¢·îñ°Ì¤Ç¿Ê¹Ô¤¹¤ëÃæ°ÀÅÙ¡¢½µÃ±°Ì¤Ç¿Ê¹Ô¤¹¤ë¹â°ÀÅ٤ʤÉ)¡£
°ìÈÌŪ¤ËÄã°ÀÅ٤Τâ¤Î¤Ë¤Ï¡¢ßÉ˦À¥ê¥ó¥Ñ¼ð¡¢MALT¥ê¥ó¥Ñ¼ð¤Ê¤É¤¬³ºÅö¤·¡¢Ãæ°ÀÅ٤Τâ¤Î¤Ë¤Ï¤Ó¤Þ¤óÀÂçºÙ˦À£ÂºÙ˦À¥ê¥ó¥Ñ¼ð¤ä̤ʬ²½ÂçºÙ˦¥ê¥ó¥Ñ¼ð¤Ê¤É¡¢¹â°ÀÅ٤Τâ¤Î¤Ë¤Ï¥ê¥ó¥Ñ²êµåÀ¥ê¥ó¥Ñ¼ð¡¢¥Ð¡¼¥¥Ã¥È¥ê¥ó¥Ñ¼ð¤Ê¤É¤¬³ºÅö¤·¤Þ¤¹¡£
¤³¤Î¤è¤¦¤Ë¡¢¡Ö°À¥ê¥ó¥Ñ¼ð¡×¤È¤¤¤¦ÉÂ̾¤Ï¡¢¤µ¤Þ¤¶¤Þ¤Ê¥ê¥ó¥Ñ·ÏÁÈ¿¥¤Î°À¼ðáç¤òÂ礤¯¤Þ¤È¤á¤Æ¸Æ¤ó¤Ç¤¤¤Þ¤¹¡£¤½¤ì¤¾¤ìÀ¼Á¤¬°Û¤Ê¤ë¤¿¤á¡¢ºÇŬ¤Ê¼£ÎŤòÁªÂò¤¹¤ë¾å¤Ç¤Ï¡¢Ž¢°À¥ê¥ó¥Ñ¼ð¤ÎÃæ¤Î¤É¤Î¤è¤¦¤Ê¥¿¥¤¥×¤Ê¤Î¤«Ž£¤È¤¤¤¦¤³¤È¤¬Èó¾ï¤Ë½ÅÍפˤʤäƤ¤Þ¤¹¡£
¾åµ¤Î¤è¤¦¤Ê¼ç¤Ë¾Ã²½´É¤Ë¤Ä¤¤¤Æ¤Ï¡¢°Ê²¼¤Î¤è¤¦¤ËÀâÌÀ¤Ç¤¤ë¤È»×¤ï¤ì¤Þ¤¹¡£
¾Ã²½´É¥ê¥ó¥Ñ¼ð¤Ï¡¢Àá³°À¥ê¥ó¥Ñ¼ð¤Î35¡ó¤òÀê¤á¡¢¤Û¤È¤ó¤É¤ÏÈó¥Û¥¸¥¥óBºÙ˦¥ê¥ó¥Ñ¼ð¤Ç¤¹¡£¹¥È¯Éô°Ì¤Ï°ß¡Ê40¡Á70¡ó¡Ë¡¢²óIJ¡ÊÌó30¡ó¡Ë¡¢ÂçIJ¡ÊÌó10¡ó¡Ë¤Ç¡¢¿©Æ»¤È½½Æó»ØÄ²¤ÎȯÀ¸Îã¤Ï¾¯¤Ê¤¤¤Ç¤¹¡£
¾Ã²½´É¥ê¥ó¥Ñ¼ð¤ÎÂçÉôʬ¤ÏBºÙ˦À¥ê¥ó¥Ñ¼ð¤ËÀê¤á¤é¤ì¡¢¤Ó¤Þ¤óÀÂçºÙ˦·¿BºÙ˦¥ê¥ó¥Ñ¼ð¡Êdiffuse large B-cell lymphoma¡§DLBCL¡Ë¤¬ºÇ¤â¿¤¯¡¢¼¡¤¤¤ÇÄã°ÀÅÙMALT¥ê¥ó¥Ñ¼ð¤ÎMarginal zone B-cell lymphoma¤¬Â³¤¤Þ¤¹¡£
°ßMALT¥ê¥ó¥Ñ¼ð¤Ç¤Ï¡¢¥Ø¥ê¥³¥Ð¥¯¥¿¡¼¡¦¥Ô¥í¥ê´¶À÷¤È´ØÏ¢¤¬¤ß¤é¤ì¡¢½ü¶Ý¤Ë¤è¤ê60¡Á80¡ó¤¬´²²ò¤·¤Þ¤¹¡£¤¿¤À¡¢t(11¡¨18)(q21¡¨q21)žºÂ¤ÎËÜÂΤǤ¢¤ëAPI2-MALT¥¥á¥é°äÅÁ»Ò¤òͤ¹¤ë¾ÉÎã¤Ç¤Ï¡¢½ü¶Ý¤¬Ìµ¸ú¤Ç¤¢¤ë¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£
¤¿¤À¡¢¼ÂºÝ¤Ët¡Ê11¡¨18¡ËžºÂ¤ò¤¹¤Ù¤Æ¤Î¾ÉÎã¤Ç¸¡º÷¤¹¤ë¤Î¤Ïº¤Æñ¤Ç¤¢¤ë¤¿¤á¡¢stage¶¤Þ¤Ç¤ÎÄã°ÀÅÙ¤ÎH.pylori¡¡ÍÛÀ°ßMALT¥ê¥ó¥Ñ¼ð¤Ë¤ª¤¤¤Æ¤Ï¡¢¼£ÎŤÎÂè1ÁªÂò¤È¤·¤Æ½ü¶ÝÎÅË¡¤ò¹Ô¤¦¤Î¤¬¸½¼ÂŪ¤Ç¤¢¤ë¤È¹Í¤¨¤é¤ì¤Þ¤¹¡£
½ü¶Ý̵¸úÎã¤ËÂФ·¤Æ¤Ï¡¢°ßÁ´Å¦½Ñ¤äÁ´°ßÊü¼ÍÀþÎÅË¡¡Ê30¥°¥ì¥¤¡Ë¡¢CHOPÎÅË¡(¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥É¡¢¥¢¥É¥ê¥¢¥Þ¥¤¥·¥ó ¡¢¥Ó¥ó¥¯¥ê¥¹¥Á¥ó¡¢¥×¥ì¥É¥Ë¥¾¥í¥ó )3¡Á5¥³¡¼¥¹¤Ë¡¢Êü¼ÍÀþÎÅË¡30¥°¥ì¥¤¤ä¹³CD20¹³ÂΡʥê¥Ä¥¥·¥Þ¥Ö¡Ë¤òÊ»ÍѤ¹¤ë¤³¤È¤¬Â¿¤¤¤Ç¤¹¡£
IJ´É¥ê¥ó¥Ñ¼ð¤Î¤Û¤È¤ó¤É¤Ï¡¢MALT·¿BºÙ˦¼ð¤Ç¤¢¤ê¡¢Â¿¤¯¤Ï¾®Ä²¤ËȯÀ¸¤·¡¢ÂçIJ¥ê¥ó¥Ñ¼ð¤Ï¤Þ¤ì(Ìó9¡óÄøÅÙ)¤Ç¤¹¡£¼ðáî·ÁÀ®ÀIJ´ÉMALT¥ê¥ó¥Ñ¼ð¤Î¿¤¯¤Ï¡¢high grade¤Ç°ßMALT¥ê¥ó¥Ñ¼ð¤Û¤Éͽ¸å¤Ï¤è¤¯¤Ê¤¤¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£
¼£ÎÅË¡¤È¤·¤Æ¤Ï¡¢¸Â¶É´ü(Stage µ¡Á¶1)¤Îhigh grade¥ê¥ó¥Ñ¼ð¤Ç¤Ï¡¢¼ðáîÉô¤ò´Þ¤àÉôʬÀÚ½ü¤È½Ñ¸åCHOP3¥³¡¼¥¹¤ÈÊü¼ÍÀþÎÅË¡¤Ê¤É¤¬¹Ô¤ï¤ì¤Þ¤¹¡£Êü¼ÍÀþÎÅË¡º¤ÆñÎã¤Ç¤Ï¡¢CHOP8¥³¡¼¥¹¤òÄɲä·¤Þ¤¹¡£¿Ê¹Ô´ü¤Ç¤Î²½³ØÎÅË¡Á°¤ÎÉÂÊÑÀÚ½ü¤Ï°ß¥ê¥ó¥Ñ¼ð¤Û¤É³ÎΩ¤µ¤ì¤Æ¤ª¤é¤º¡¢²½³ØÎÅË¡¤¬Ãæ¿´¤È¤Ê¤ê¤Þ¤¹¡£
ËýÀ±ê¾É¤¬¡¢°À¥ê¥ó¥Ñ¼ð¤Î¥È¥ê¥¬¡¼¤È¤Ê¤ë²ÄǽÀ¤¬¤¢¤ë¡¢¤È¤¤¤¦¤Î¤Ï¡¢¥Ô¥í¥ê¶Ý¤È¤Î´ØÏ¢À¤¬»ØÅ¦¤µ¤ì¤Æ¤¤¤ë¤³¤È¤ò¹Í¤¨¤ë¤È¡¢Ç¼ÆÀ¤·¤ä¤¹¤¤¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£º£¸å¡¢¤½¤Îµ¡½ø¤¬²òÌÀ¤µ¤ì¤ì¤Æ¾ÜºÙ¤¬È½ÌÀ¤¹¤ì¤Ð¡¢¿·¤¿¤Ê¼£ÎÅË¡³«È¯¤ËÂ礤ʰì½õ¤È¤Ê¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£
¡Ú´ØÏ¢µ»ö¡Û
°À¥ê¥ó¥Ñ¼ð¤Î¿·Ìô¡Ý¥Õ¥ë¥À¥é¡¢¥»¥ô¥¡¥ê¥ó
ÈéÉæ°À¥ê¥ó¥Ñ¼ð¡ÝÀÖ¤¤¼¾¿¾¤Ë¤´Ãí°Õ
°À¥ê¥ó¥Ñ¼ð¤ËÂФ¹¤ëÊü¼ÍÀþ¼£ÎŤò¼õ¤±¤¿¡Ý°¦²Ú¤ß¤ì¤µ¤ó
¾Ã²½´É¥ê¥ó¥Ñ¼ð¤ÎÂçÉôʬ¤ÏBºÙ˦À¥ê¥ó¥Ñ¼ð¤ËÀê¤á¤é¤ì¡¢¤Ó¤Þ¤óÀÂçºÙ˦·¿BºÙ˦¥ê¥ó¥Ñ¼ð¡Êdiffuse large B-cell lymphoma¡§DLBCL¡Ë¤¬ºÇ¤â¿¤¯¡¢¼¡¤¤¤ÇÄã°ÀÅÙMALT¥ê¥ó¥Ñ¼ð¤ÎMarginal zone B-cell lymphoma¤¬Â³¤¤Þ¤¹¡£
°ßMALT¥ê¥ó¥Ñ¼ð¤Ç¤Ï¡¢¥Ø¥ê¥³¥Ð¥¯¥¿¡¼¡¦¥Ô¥í¥ê´¶À÷¤È´ØÏ¢¤¬¤ß¤é¤ì¡¢½ü¶Ý¤Ë¤è¤ê60¡Á80¡ó¤¬´²²ò¤·¤Þ¤¹¡£¤¿¤À¡¢t(11¡¨18)(q21¡¨q21)žºÂ¤ÎËÜÂΤǤ¢¤ëAPI2-MALT¥¥á¥é°äÅÁ»Ò¤òͤ¹¤ë¾ÉÎã¤Ç¤Ï¡¢½ü¶Ý¤¬Ìµ¸ú¤Ç¤¢¤ë¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£
¤¿¤À¡¢¼ÂºÝ¤Ët¡Ê11¡¨18¡ËžºÂ¤ò¤¹¤Ù¤Æ¤Î¾ÉÎã¤Ç¸¡º÷¤¹¤ë¤Î¤Ïº¤Æñ¤Ç¤¢¤ë¤¿¤á¡¢stage¶¤Þ¤Ç¤ÎÄã°ÀÅÙ¤ÎH.pylori¡¡ÍÛÀ°ßMALT¥ê¥ó¥Ñ¼ð¤Ë¤ª¤¤¤Æ¤Ï¡¢¼£ÎŤÎÂè1ÁªÂò¤È¤·¤Æ½ü¶ÝÎÅË¡¤ò¹Ô¤¦¤Î¤¬¸½¼ÂŪ¤Ç¤¢¤ë¤È¹Í¤¨¤é¤ì¤Þ¤¹¡£
½ü¶Ý̵¸úÎã¤ËÂФ·¤Æ¤Ï¡¢°ßÁ´Å¦½Ñ¤äÁ´°ßÊü¼ÍÀþÎÅË¡¡Ê30¥°¥ì¥¤¡Ë¡¢CHOPÎÅË¡(¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥É¡¢¥¢¥É¥ê¥¢¥Þ¥¤¥·¥ó ¡¢¥Ó¥ó¥¯¥ê¥¹¥Á¥ó¡¢¥×¥ì¥É¥Ë¥¾¥í¥ó )3¡Á5¥³¡¼¥¹¤Ë¡¢Êü¼ÍÀþÎÅË¡30¥°¥ì¥¤¤ä¹³CD20¹³ÂΡʥê¥Ä¥¥·¥Þ¥Ö¡Ë¤òÊ»ÍѤ¹¤ë¤³¤È¤¬Â¿¤¤¤Ç¤¹¡£
IJ´É¥ê¥ó¥Ñ¼ð¤Î¤Û¤È¤ó¤É¤Ï¡¢MALT·¿BºÙ˦¼ð¤Ç¤¢¤ê¡¢Â¿¤¯¤Ï¾®Ä²¤ËȯÀ¸¤·¡¢ÂçIJ¥ê¥ó¥Ñ¼ð¤Ï¤Þ¤ì(Ìó9¡óÄøÅÙ)¤Ç¤¹¡£¼ðáî·ÁÀ®ÀIJ´ÉMALT¥ê¥ó¥Ñ¼ð¤Î¿¤¯¤Ï¡¢high grade¤Ç°ßMALT¥ê¥ó¥Ñ¼ð¤Û¤Éͽ¸å¤Ï¤è¤¯¤Ê¤¤¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£
¼£ÎÅË¡¤È¤·¤Æ¤Ï¡¢¸Â¶É´ü(Stage µ¡Á¶1)¤Îhigh grade¥ê¥ó¥Ñ¼ð¤Ç¤Ï¡¢¼ðáîÉô¤ò´Þ¤àÉôʬÀÚ½ü¤È½Ñ¸åCHOP3¥³¡¼¥¹¤ÈÊü¼ÍÀþÎÅË¡¤Ê¤É¤¬¹Ô¤ï¤ì¤Þ¤¹¡£Êü¼ÍÀþÎÅË¡º¤ÆñÎã¤Ç¤Ï¡¢CHOP8¥³¡¼¥¹¤òÄɲä·¤Þ¤¹¡£¿Ê¹Ô´ü¤Ç¤Î²½³ØÎÅË¡Á°¤ÎÉÂÊÑÀÚ½ü¤Ï°ß¥ê¥ó¥Ñ¼ð¤Û¤É³ÎΩ¤µ¤ì¤Æ¤ª¤é¤º¡¢²½³ØÎÅË¡¤¬Ãæ¿´¤È¤Ê¤ê¤Þ¤¹¡£
ËýÀ±ê¾É¤¬¡¢°À¥ê¥ó¥Ñ¼ð¤Î¥È¥ê¥¬¡¼¤È¤Ê¤ë²ÄǽÀ¤¬¤¢¤ë¡¢¤È¤¤¤¦¤Î¤Ï¡¢¥Ô¥í¥ê¶Ý¤È¤Î´ØÏ¢À¤¬»ØÅ¦¤µ¤ì¤Æ¤¤¤ë¤³¤È¤ò¹Í¤¨¤ë¤È¡¢Ç¼ÆÀ¤·¤ä¤¹¤¤¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£º£¸å¡¢¤½¤Îµ¡½ø¤¬²òÌÀ¤µ¤ì¤ì¤Æ¾ÜºÙ¤¬È½ÌÀ¤¹¤ì¤Ð¡¢¿·¤¿¤Ê¼£ÎÅË¡³«È¯¤ËÂ礤ʰì½õ¤È¤Ê¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£
¡Ú´ØÏ¢µ»ö¡Û
°À¥ê¥ó¥Ñ¼ð¤Î¿·Ìô¡Ý¥Õ¥ë¥À¥é¡¢¥»¥ô¥¡¥ê¥ó
ÈéÉæ°À¥ê¥ó¥Ñ¼ð¡ÝÀÖ¤¤¼¾¿¾¤Ë¤´Ãí°Õ
°À¥ê¥ó¥Ñ¼ð¤ËÂФ¹¤ëÊü¼ÍÀþ¼£ÎŤò¼õ¤±¤¿¡Ý°¦²Ú¤ß¤ì¤µ¤ó